ArticleEuropean journal of medicinal chemistry2019

Human constitutive androstane receptor agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies.

Dongdong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.